541 – 550 of 5999
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Improving smoking cessation after myocardial infarction by systematically implementing evidence-based treatment methods
(
- Contribution to journal › Article
-
Mark
Data on plasma tumour and metabolism related proteins’ potential in differentiation of HFpEF-PH from PAH and in prognosis of left heart failure patients with pulmonary hypertension
(
- Contribution to journal › Article
-
Mark
Plasma Proneurotensin and Prediction of Cause-Specific Mortality in a Middle-aged Cohort During Long-term Follow-up
(
- Contribution to journal › Article
-
Mark
Hemodynamic force analysis is not ready for clinical trials on HFpEF
(
- Contribution to journal › Article
-
Mark
How to calculate ventricular–arterial coupling?
(
- Contribution to journal › Letter
-
Mark
Common physiologic and proteomic biomarkers in pulmonary and coronary artery disease
(
- Contribution to journal › Article
-
Mark
Simple cardiovascular risk stratification by replacing total serum cholesterol with anthropometric measures : The MORGAM prospective cohort project
(
- Contribution to journal › Article
-
Mark
Optimizing Percutaneous Coronary Intervention
2022) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
The Authors' Reply to the Letter “Plasma tumour and metabolism related biomarkers differentiate PAH from HFpEF-PH may improve long-term prognosis”
(
- Contribution to journal › Letter
-
Mark
High versus low-added sugar consumption for the primary prevention of cardiovascular disease
(
- Contribution to journal › Scientific review